368 related articles for article (PubMed ID: 21575916)
1. Interferon regulatory factors in human lupus pathogenesis.
Salloum R; Niewold TB
Transl Res; 2011 Jun; 157(6):326-31. PubMed ID: 21575916
[TBL] [Abstract][Full Text] [Related]
2. Interferon regulatory factors: critical mediators of human lupus.
Jensen MA; Niewold TB
Transl Res; 2015 Feb; 165(2):283-95. PubMed ID: 25445206
[TBL] [Abstract][Full Text] [Related]
3. Interferon regulatory factor 5 in the pathogenesis of systemic lupus erythematosus.
Cham CM; Ko K; Niewold TB
Clin Dev Immunol; 2012; 2012():780436. PubMed ID: 23251221
[TBL] [Abstract][Full Text] [Related]
4. IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus.
Niewold TB; Kelly JA; Kariuki SN; Franek BS; Kumar AA; Kaufman KM; Thomas K; Walker D; Kamp S; Frost JM; Wong AK; Merrill JT; Alarcón-Riquelme ME; Tikly M; Ramsey-Goldman R; Reveille JD; Petri MA; Edberg JC; Kimberly RP; Alarcón GS; Kamen DL; Gilkeson GS; Vyse TJ; James JA; Gaffney PM; Moser KL; Crow MK; Harley JB
Ann Rheum Dis; 2012 Mar; 71(3):463-8. PubMed ID: 22088620
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation near IRF8 is associated with serologic and cytokine profiles in systemic lupus erythematosus and multiple sclerosis.
Chrabot BS; Kariuki SN; Zervou MI; Feng X; Arrington J; Jolly M; Boumpas DT; Reder AT; Goulielmos GN; Niewold TB
Genes Immun; 2013 Dec; 14(8):471-8. PubMed ID: 23965942
[TBL] [Abstract][Full Text] [Related]
6. Linking interferon regulatory factors to the pathogenesis of human lupus.
Patel DR
Transl Res; 2011 Jun; 157(6):323-5. PubMed ID: 21575915
[No Abstract] [Full Text] [Related]
7. Interferon alpha as a primary pathogenic factor in human lupus.
Niewold TB
J Interferon Cytokine Res; 2011 Dec; 31(12):887-92. PubMed ID: 21923413
[TBL] [Abstract][Full Text] [Related]
8. The potential role of interferon-regulatory factor 7 among Taiwanese patients with systemic lupus erythematosus.
Lin LH; Ling P; Liu MF
J Rheumatol; 2011 Sep; 38(9):1914-9. PubMed ID: 21632682
[TBL] [Abstract][Full Text] [Related]
9. Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon-alpha activity in lupus patients.
Salloum R; Franek BS; Kariuki SN; Rhee L; Mikolaitis RA; Jolly M; Utset TO; Niewold TB
Arthritis Rheum; 2010 Feb; 62(2):553-61. PubMed ID: 20112359
[TBL] [Abstract][Full Text] [Related]
10. Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice.
Tada Y; Kondo S; Aoki S; Koarada S; Inoue H; Suematsu R; Ohta A; Mak TW; Nagasawa K
Arthritis Rheum; 2011 Mar; 63(3):738-48. PubMed ID: 21305501
[TBL] [Abstract][Full Text] [Related]
11. A compass that points to lupus: genetic studies on type I interferon pathway.
Kyogoku C; Tsuchiya N
Genes Immun; 2007 Sep; 8(6):445-55. PubMed ID: 17581625
[TBL] [Abstract][Full Text] [Related]
12. Interferon regulatory factor 3 as key element of the interferon signature in plasmacytoid dendritic cells from systemic lupus erythematosus patients: novel genetic associations in the Mexican mestizo population.
Santana-de Anda K; Gómez-Martín D; Monsivais-Urenda AE; Salgado-Bustamante M; González-Amaro R; Alcocer-Varela J
Clin Exp Immunol; 2014 Dec; 178(3):428-37. PubMed ID: 25130328
[TBL] [Abstract][Full Text] [Related]
13. Genetic Versus Non-genetic Drivers of SLE: Implications of IRF5 Dysregulation in Both Roads Leading to SLE.
Barnes BJ
Curr Rheumatol Rep; 2019 Jan; 21(1):2. PubMed ID: 30645688
[TBL] [Abstract][Full Text] [Related]
14. The
Devaraju P; Mehra S; Gulati R; Antony PT; Jain VK; Misra DP; Negi VS
Indian J Med Res; 2018 Jun; 147(6):560-566. PubMed ID: 30168487
[TBL] [Abstract][Full Text] [Related]
15. Genetic variants and disease-associated factors contribute to enhanced interferon regulatory factor 5 expression in blood cells of patients with systemic lupus erythematosus.
Feng D; Stone RC; Eloranta ML; Sangster-Guity N; Nordmark G; Sigurdsson S; Wang C; Alm G; Syvänen AC; Rönnblom L; Barnes BJ
Arthritis Rheum; 2010 Feb; 62(2):562-73. PubMed ID: 20112383
[TBL] [Abstract][Full Text] [Related]
16. Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients.
Niewold TB; Kelly JA; Flesch MH; Espinoza LR; Harley JB; Crow MK
Arthritis Rheum; 2008 Aug; 58(8):2481-7. PubMed ID: 18668568
[TBL] [Abstract][Full Text] [Related]
17. Interferon pathway lupus risk alleles modulate risk of death from acute COVID-19.
Nln I; Fernandez-Ruiz R; Muskardin TLW; Paredes JL; Blazer AD; Tuminello S; Attur M; Iturrate E; Petrilli CM; Abramson SB; Chakravarti A; Niewold TB
Transl Res; 2022 Jun; 244():47-55. PubMed ID: 35114420
[TBL] [Abstract][Full Text] [Related]
18. The genetics and biology of Irf5-mediated signaling in lupus.
Kozyrev SV; Alarcon-Riquelme ME
Autoimmunity; 2007 Dec; 40(8):591-601. PubMed ID: 18075793
[TBL] [Abstract][Full Text] [Related]
19. Hematopoietic stem cell transplant for systemic lupus erythematosus: Interferon regulatory factor 7 activation correlates with the IFN signature and recurrent disease.
Sweeney SE
Lupus; 2011 Aug; 20(9):975-80. PubMed ID: 21576205
[TBL] [Abstract][Full Text] [Related]
20. Association of IRF5 polymorphisms with activation of the interferon alpha pathway.
Rullo OJ; Woo JM; Wu H; Hoftman AD; Maranian P; Brahn BA; McCurdy D; Cantor RM; Tsao BP
Ann Rheum Dis; 2010 Mar; 69(3):611-7. PubMed ID: 19854706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
